Success Planning For An Original NDA/BLA Submission

This comprehensive webinar provides an in-depth examination of New Drug Applications (NDAs) and Biologics License Applications (BLAs), essential for pharmaceutical companies seeking approval for new drugs and biologics. Participants will gain crucial knowledge and resources to navigate the NDA/BLA process effectively.

Led by experienced experts in regulatory strategy, operations, and program leadership, attendees will learn successful planning strategies for original NDA/BLA submissions. Topics covered include initiation triggers, team coordination, submission processes, and Electronic Submission Gateway (ESG) utilization.

At Halloran, we're dedicated to improving human health by providing innovative therapies. This webinar aligns with our mission by empowering pharmaceutical professionals to develop and approve groundbreaking treatments, addressing unmet medical needs worldwide.